
  
    
      
        Introduction_NNP
        Rheumatoid_NNP arthritis_NN (_( RA_NNP )_) is_VBZ a_DT chronic_JJ inflammatory_JJ
        disease_NN of_IN the_DT synovial_NN joints_NNS ,_, which_WDT can_MD result_VB in_IN
        articular_NN cartilage_NN and_CC bone_NN destruction_NN ,_, leading_VBG to_TO
        significant_JJ disability_NN ._. Central_NNP pathophysiological_JJ features_NNS
        of_IN the_DT disease_NN occur_VB in_IN the_DT synovium_NN ,_, with_IN thickening_VBG of_IN
        the_DT lining_NN layer_NN (_( or_CC intima_NN )_) and_CC infiltration_NN of_IN the_DT
        sublining_VBG layer_NN ,_, mainly_RB by_IN macrophages_NNS and_CC lymphocytes_NNS [_NN 1_CD
        ]_NN ._. In_IN addition_NN ,_, the_DT fluid-filled_JJ joint_JJ cavity_NN contains_VBZ
        numerous_JJ neutrophils_NNS ,_, particularly_RB during_IN acute_JJ flares_NNS of_IN
        RA_NNP [_NN 2_CD ]_NN ._.
        The_DT normal_JJ intima_NN of_IN the_DT synovium_NN is_VBZ one_CD to_TO two_CD cells_NNS
        thick_JJ and_CC consists_VBZ mainly_RB of_IN macrophage-like_JJ and_CC
        fibroblast-like_JJ cells_NNS [_NN 3_CD ]_NN ._. In_IN inflammation_NN ,_, macrophages_NNS
        make_VBP a_DT large_JJ contribution_NN to_TO intimal_NN thickening_VBG ,_, where_WRB
        these_DT cells_NNS increase_VBP in_IN number_NN and_CC proportion_NN [_NN 3_CD ]_NN ._.
        Evidence_NN indicates_VBZ that_IN intimal_NN macrophages_NNS arrive_VBP via_IN the_DT
        circulation_NN as_IN monocytes_NNS [_NN 4_CD ]_NN ,_, and_CC it_PRP is_VBZ proposed_VBN that_WDT
        increased_VBN numbers_NNS of_IN intimal_NN macrophages_NNS in_IN RA_NNP are_VBP largely_RB
        attributed_VBN to_TO enhanced_JJ monocyte_NN recruitment_NN from_IN blood_NN
        vessels_NNS in_IN the_DT synovium_NN [_NN 1_CD 5_CD ]_NN ._. Neutrophils_NNP are_VBP also_RB
        recruited_VBN in_IN RA_NNP and_CC can_MD be_VB found_VBN in_IN abundance_NN in_IN synovial_NN
        fluid_JJ ,_, yet_RB they_PRP occur_VBP in_IN relatively_RB low_JJ numbers_NNS in_IN the_DT
        synovium_NN [_NN 5_CD ]_NN ._. In_IN synovial_NN fluid_JJ their_PRP$ number_NN can_MD reach_VB
        10_CD 6_CD per_IN joint_JJ ,_, particularly_RB during_IN an_DT active_JJ phase_NN of_IN the_DT
        disease_NN [_NN 6_CD ]_NN ._. Neutrophils_NNP occur_VB at_IN the_DT pannus-cartilage_JJ
        junction_NN [_NN 7_CD ]_NN and_CC it_PRP is_VBZ presumed_VBN that_IN these_DT cells_NNS reach_VBP
        the_DT joint_JJ cavity_NN by_IN migrating_VBG from_IN the_DT blood_NN vessels_NNS in_IN the_DT
        synovium_NN ,_, following_VBG a_DT chemotactic_JJ gradient_NN ._.
        Chemokines_NNP are_VBP a_DT family_NN of_IN proinflammatory_NN cytokines_NNS ,_,
        which_WDT are_VBP strongly_RB implicated_VBN in_IN inducing_VBG migration_NN of_IN
        leukocytes_NNS from_IN the_DT blood_NN into_IN inflammatory_JJ lesions_NNS ._.
        Evidence_NN has_VBZ accumulated_VBN to_TO suggest_VB that_IN chemokines_NNS ,_, such_JJ
        as_IN CXCL_NNP 8_CD (_( IL-_NNP 8_CD )_) ,_, CXCL_NNP 5_CD (_( epithelial_NN cell-derived_JJ
        neutrophil-activating_JJ protein_NN )_) ,_, CCL_NNP 2_CD (_( monocyte_NN
        chemoattractant_NN protein-_NN 1_LS )_) ,_, CCL_NNP 3_CD (_( macrophage_NN inflammatory_JJ
        protein-_NN 1_CD α_NN )_) and_CC CCL_NNP 5_CD (_( RANTES_NNP )_) ,_, direct_VB the_DT migration_NN of_IN
        leukocytes_NNS into_IN the_DT RA_NNP synovium_NN and_CC joint_JJ fluid_JJ [_NN 8_CD ]_NN ._.
        Chemokines_NNP occur_VB in_IN significantly_RB elevated_VBD levels_NNS in_IN human_JJ
        RA_NNP synovial_NN fluid_JJ ,_, where_WRB they_PRP are_VBP biologically_RB active_JJ ,_, and_CC
        are_VBP expressed_VBN by_IN cells_NNS of_IN the_DT synovium_NN and_CC cartilage_NN ._.
        Tumour_NNP necrosis_NNS factor-α_JJ blockade_NN reduces_VBZ synovial_NN
        expression_NN of_IN CCL_NNP 2_CD and_CC CXCL_NNP 8_CD and_CC reduces_VBZ inflammatory_JJ cell_NN
        migration_NN into_IN RA_NNP joints_NNS [_NN 9_CD ]_NN ._. In_IN addition_NN ,_, these_DT
        chemokines_NNS ,_, produced_VBN by_IN RA_NNP synovial_NN stromal_NN cells_NNS ,_, have_VBP
        been_VBN shown_VBN to_TO stimulate_VB monocyte_NN migration_NN [_NN 10_CD ]_NN ._. The_DT
        functional_JJ importance_NN of_IN chemokines_NNS in_IN joint_JJ inflammation_NN
        has_VBZ also_RB been_VBN established_VBN in_IN animal_NN models_NNS of_IN RA_NNP where_WRB
        antibodies_NNS to_TO these_DT mediators_NNS significantly_RB reduce_VBP both_DT the_DT
        number_NN of_IN leukocytes_NNS recruited_VBN and_CC the_DT severity_NN of_IN disease_NN ._.
        In_IN addition_NN ,_, administration_NN of_IN chemokines_NNS to_TO the_DT joints_NNS of_IN
        animal_NN models_NNS results_NNS in_IN inflammation_NN and_CC leukocyte_NN
        recruitment_NN ._.
        The_DT biological_JJ effects_NNS of_IN chemokines_NNS are_VBP mediated_JJ by_IN
        binding_JJ to_TO G-_NNP protein-coupled_JJ ,_, seven_CD transmembrane_NN domain_NN ,_,
        chemokine_NN receptors_NNS [_NN 11_CD ]_NN ._. CC_NNP receptors_NNS (_( CCR_NNP )_) bind_NN
        members_NNS of_IN the_DT class_NN of_IN chemokines_NNS with_IN two_CD adjacent_JJ
        cysteine_NN (_( C_NNP )_) residues_NNS near_IN the_DT NH_NNP 
        2_CD -_: terminus_JJ (_( CC_NNP ;_: e_SYM ._. g_SYM ._. CCL_NNP 2_CD ,_, CCL_NNP 3_CD and_CC
        CCL_NNP 5_LS )_) and_CC CXC_NNP receptors_NNS (_( CXCR_NNP )_) bind_NN members_NNS of_IN the_DT class_NN of_IN
        chemokines_NNS with_IN C_NNP separated_VBN by_IN an_DT amino_JJ acid_NN defined_VBN as_IN X_NNP
        (_( CXC_NNP ;_: e_SYM ._. g_SYM ._. CXCL_NNP 5_CD and_CC CXCL_NNP 8_CD )_) ._. There_EX have_VBP been_VBN some_DT reports_NNS
        on_IN the_DT expression_NN of_IN such_JJ receptors_NNS on_IN T_NN cells_NNS in_IN synovial_NN
        tissue_NN and_CC fluid_JJ [_NN 12_CD 13_CD 14_CD 15_CD 16_CD ]_NN ._. Little_NNP is_VBZ known_VBN about_IN
        the_DT expression_NN of_IN chemokine_NN receptors_NNS on_IN phagocytes_NNS in_IN the_DT
        human_JJ RA_NNP synovium_NN ._. One_CD recent_JJ study_NN has_VBZ shown_VBN the_DT protein_NN
        expression_NN of_IN several_JJ chemokine_NN receptors_NNS on_IN
        monocytes_NNS /_NN macrophages_NNS in_IN RA_NNP blood_NN ,_, synovium_NN and_CC synovial_NN
        fluid_JJ [_NN 17_CD ]_NN ._. The_DT aim_NN of_IN the_DT present_JJ study_NN ,_, therefore_RB ,_, was_VBD
        to_TO examine_VB the_DT expression_NN of_IN 
        in_IN situ_NN chemokine_NN binding_JJ sites_NNS on_IN
        macrophages_NNS and_CC neutrophils_NNS that_WDT could_MD mediate_VB the_DT
        migration_NN of_IN these_DT cells_NNS into_IN the_DT inflamed_JJ synovium_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Tissue_NNP source_NN
          Tissue_NNP samples_NNS were_VBD obtained_VBN from_IN patients_NNS with_IN RA_NNP (_( 
          n_NN =_SYM 6_CD )_) who_WP fulfilled_VBD the_DT American_NNP
          Rheumatism_NNP Association_NNP criteria_NNS for_IN RA_NNP (_( Supplementary_NNP
          Table_NNP 1_LS )_) ._. Synovia_NNP were_VBD taken_VBN from_IN these_DT subjects_NNS at_IN total_JJ
          knee_NN replacement_NN (_( patients_NNS 1_CD ,_, 3_CD -_: 5_LS )_) or_CC knee_NN synovectomy_NN
          operations_NNS (_( patients_NNS 2_CD and_CC 6_CD )_) ._. Non-_NNP RA_NNP patients_NNS (_( 
          n_NN =_SYM 6_CD )_) had_VBD knee_NN joint_JJ symptoms_NNS for_IN
          suspected_VBN articular_NN cartilage_NN ,_, meniscal_NN or_CC anterior_NN
          cruciate_NN ligament_NN damage_NN (_( patients_NNS 7_CD -_: 12_CD )_) ._. Knee_NN joint_JJ
          synovial_NN biopsies_NNS were_VBD obtained_VBN from_IN these_DT non-_NN RA_NNP
          individuals_NNS ,_, with_IN informed_VBN consent_NN ,_, at_IN arthroscopy_NN ._. For_IN
          RA_NNP and_CC non-_NN RA_NNP patients_NNS ,_, samples_NNS were_VBD taken_VBN from_IN the_DT
          suprapatel-lar_JJ pouch_NN and_CC medial_NN gutter_NN ,_, which_WDT is_VBZ reported_VBN
          to_TO provide_VB representative_NN sampling_VBG of_IN synovial_NN membrane_NN
          pathology_NN [_NN 18_CD ]_NN ._.
        
        
          In_IN situbinding_VBG autoradiography_NN
          The_DT method_NN of_IN Hub_NNP and_CC Rot_NNP [_NN 19_CD ]_NN was_VBD followed_VBN ,_, with_IN
          minor_JJ modifications_NNS (_( see_VB Supplementary_NNP Material_NNP )_) ._.
        
        
          Identification_NNP of_IN macrophages_NNS and_CC
          neutrophils_NNS
          Representative_NNP sections_NNS of_IN synovia_NN that_WDT had_VBD been_VBN
          incubated_JJ with_IN 125_CD I-_NNP labeled_VBD chemokines_NNS were_VBD immunostained_JJ
          for_IN CD_NNP 68_CD as_IN a_DT marker_NN for_IN macrophages_NNS ._. Slides_NNS were_VBD
          deparafinized_JJ ,_, rehydrated_JJ and_CC treated_VBN with_IN 1_CD %_NN pronase_NN for_IN
          seven_CD minutes_NNS at_IN room_NN temperature_NN ._. Following_VBG blocking_VBG of_IN
          endogenous_JJ peroxidase_NN ,_, sections_NNS were_VBD treated_VBN with_IN normal_JJ
          horse_NN serum_NN and_CC incubated_JJ with_IN 2_CD ._. 5_CD μg_NN /_NN ml_NN anti-_NN CD_NNP 68_CD
          monoclonal_NN antibody_NN (_( PG-M_NNP 1_CD ,_, Dako_NNP A_DT /_NN S_NNP ,_, Glostrup_NNP ,_, Denmark_NNP )_)
          in_IN PBS_NNP /_NN normal_JJ horse_NN serum_NN ._. The_DT bound_VBN antibody_NN was_VBD
          detected_VBN using_VBG biotinylated_JJ second_JJ antibody_NN ,_,
          avidin-peroxidase_JJ conjugate_NN and_CC diaminobenzidine_NN
          substrate_NN (_( Vectastain_NNP ABC_NNP Elite_NNP Kit_NNP ;_: Vector_NNP Labs_NNPS ,_,
          Burlingame_NNP ,_, USA_NNP )_) ._. Slides_NNS were_VBD then_RB coated_VBN with_IN emulsion_NN ,_,
          exposed_VBN ,_, developed_VBN and_CC stained_JJ in_IN haematoxylin_NN ,_, as_IN for_IN 
          in_IN situ_NN binding_JJ
          autoradiography_NN ._.
          Neutrophils_NNP were_VBD identified_VBN by_IN their_PRP$ characteristic_JJ
          multi-lobed_JJ nuclei_NN in_IN haematoxylin_NN and_CC eosin_NN stained_JJ
          sections_NNS ._.
        
        
          Immunohistochemistry_NNP of_IN CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD
          Synovial_NNP samples_NNS that_WDT had_VBD been_VBN examined_VBN for_IN chemokine_NN
          binding_JJ were_VBD also_RB sectioned_JJ and_CC incubated_JJ with_IN rabbit_NN
          polyclonal_NN antibodies_NNS to_TO the_DT carboxy_NN termini_NN of_IN CXCR_NNP 1_CD and_CC
          CXCR_NNP 2_CD (_( both_DT from_IN Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_,
          USA_NNP )_) [_NN 20_CD ]_NN ._. Antibody_NNP binding_JJ was_VBD detected_VBN using_VBG an_DT
          immunoperoxidase_NN method_NN (_( Vectastain_NNP ABC_NNP Elite_NNP Kit_NNP ;_: Vector_NNP
          Labs_NNPS ,_, Burlingame_NNP ,_, USA_NNP )_) ._. See_VB Supplementary_NNP Material_NNP for_IN
          more_RBR detailed_JJ methods_NNS ._.
        
        
          Quantitation_NNP of_IN synovial_NN sections_NNS
          See_VB Supplementary_NNP Material_NNP ._.
        
      
      
        Results_NNS
        
          Tissue_NNP sampling_VBG
          In_IN all_DT six_CD RA_NNP subjects_VBZ the_DT histological_JJ appearance_NN of_IN
          synovia_NN showed_VBD classic_JJ inflammatory_JJ pathology_NN with_IN
          mononuclear_NN cell_NN infiltrates_NNS and_CC a_DT thickened_JJ intimal_NN
          layer_NN ._. In_IN two_CD of_IN these_DT individuals_NNS a_DT minority_NN of_IN synovial_NN
          samples_NNS also_RB showed_VBD microscopically_RB normal_JJ regions_NNS with_IN
          minimal_JJ infiltration_NN of_IN inflammatory_JJ cells_NNS and_CC an_DT intimal_NN
          layer_NN of_IN normal_JJ thickness_NN (_( one_CD to_TO two_CD cells_NNS thick_JJ )_) ._. The_DT
          synovia_NN of_IN the_DT six_CD non-_NN RA_NNP patients_NNS showed_VBD inflamed_JJ and_CC
          noninflamed_JJ regions_NNS ._. These_DT inflamed_JJ regions_NNS displayed_VBD
          intimal_NN layer_NN thickening_VBG and_CC some_DT infiltration_NN of_IN
          mononuclear_NN cells_NNS ,_, although_IN not_RB as_RB severe_JJ as_IN in_IN RA_NNP
          samples_NNS ,_, and_CC noninflamed_JJ sites_NNS showed_VBD a_DT normal_JJ intimal_NN
          layer_NN and_CC no_DT leukocyte_NN infiltrates_NNS ._.
        
        
          Chemokine_NNP binding_JJ to_TO macrophages_NNS
          To_TO examine_VB 
          in_IN situ_NN binding_JJ of_IN chemokines_NNS ,_,
          synovia_NN were_VBD treated_VBN with_IN 125_CD I-CXCL_NNP 8_CD ,_, 125_CD I-CCL_NNP 2_CD ,_,
          125_CD I-CCL_NNP 3_CD and_CC 125_CD I-CCL_NNP 5_CD followed_VBN by_IN autoradiogaphy_NN ._. For_IN
          direct_JJ comparison_NN ,_, each_DT chemokine_NN was_VBD added_VBN at_IN the_DT same_JJ
          specific_JJ radioactivity_NN and_CC concentration_NN ,_, and_CC
          autoradiography_NN was_VBD performed_VBN for_IN an_DT identical_JJ exposure_NN
          time_NN ._. All_DT four_CD chemokines_NNS bound_VBN to_TO synovial_NN tissue_NN cells_NNS
          in_IN the_DT subintima_NN and_CC the_DT intima_NN in_IN every_DT RA_NNP and_CC non-_NN RA_NNP
          individual_JJ (_( Supplementary_NNP Fig_NNP ._. 1_LS afor_NN CCL_NNP 5_LS )_) ._. Radiolabelled_NNP
          chemokine_NN binding_JJ was_VBD absent_JJ in_IN synovia_NN treated_VBN with_IN
          1000_CD -_: fold_VB excess_JJ homologous_RB non-radiolabelled_JJ chemokine_NN ,_,
          indicating_VBG that_IN the_DT binding_JJ sites_NNS were_VBD specific_JJ
          (_( Supplementary_NNP Fig_NNP ._. 1_LS b_SYM )_) ._. Histological_NNP examination_NN
          indicated_VBD that_IN macrophages_NNS accounted_VBD for_IN a_DT high_JJ
          proportion_NN of_IN the_DT chemokine_NN binding_JJ ,_, so_RB to_TO confirm_VB this_DT
          observation_NN ,_, representative_NN sections_NNS were_VBD immunostained_JJ
          with_IN CD_NNP 68_CD as_IN a_DT marker_NN of_IN monocytes_NNS /_NN macrophages_NNS ,_, then_RB
          processed_VBN for_IN autoradiogaphy_NN ._. All_DT four_CD chemokines_NNS bound_VBN
          to_TO CD_NNP 68_CD +_NN cells_NNS in_IN the_DT subintima_NN in_IN every_DT RA_NNP and_CC non-_NN RA_NNP
          synovial_NN sample_NN ._. No_DT major_JJ differences_NNS in_IN chemokine_NN
          binding_JJ were_VBD apparent_JJ between_IN the_DT six_CD RA_NNP patients_NNS ,_,
          despite_IN variation_NN in_IN disease_NN duration_NN and_CC drug_NN treatment_NN
          (_( Supplementary_NNP Table_NNP 1_LS )_) ._. The_DT positive_JJ cells_NNS were_VBD located_VBN
          close_RB to_TO blood_NN vessels_NNS in_IN leukocyte_NN infiltrates_NNS and_CC non_NN
          infiltrated_VBN sites_NNS ,_, and_CC in_IN more_RBR remote_JJ sites_NNS within_IN the_DT
          subintimal_NN stroma_NN (_( Fig_NNP ._. 1_LS )_) ._. In_IN addition_NN CD_NNP 68_CD +_NN macrophages_NNS
          bound_VBN all_DT four_CD chemokines_NNS in_IN the_DT intimal_NN layer_NN of_IN
          inflamed_JJ (_( Fig_NNP ._. 1_LS )_) and_CC noninflamed_JJ samples_NNS ._. In_IN control_NN
          experiments_NNS there_RB was_VBD no_DT immunostaining_VBG when_WRB
          isotype-matched_JJ control_NN mouse_NN IgG_NNP was_VBD used_VBN instead_RB of_IN the_DT
          anti-_NN CD_NNP 68_CD antibody_NN ._.
        
        
          Quantitation_NNP of_IN intimal_NN binding_JJ
          The_DT number_NN of_IN intimal_NN cells_NNS that_WDT bound_VBN chemokines_NNS were_VBD
          counted_VBN and_CC the_DT results_NNS for_IN RA_NNP and_CC non-_NN RA_NNP patients_NNS were_VBD
          expressed_VBN as_IN means_VBZ (_( Table_NNP 1_LS )_) ._. There_EX was_VBD a_DT significant_JJ
          increase_NN of_IN chemokine-positive_JJ cells_NNS in_IN inflamed_JJ intima_NN
          compared_VBN to_TO noninflamed_JJ intima_NN ,_, for_IN both_DT RA_NNP and_CC non-_NN RA_NNP
          synovia_NN ._. The_DT number_NN of_IN positive_JJ cells_NNS varied_VBD between_IN
          chemokines_NNS and_CC in_IN RA_NNP tissue_NN the_DT rank_NN order_NN was_VBD ,_, CCL_NNP 3_CD >_NN
          CCL_NNP 5_CD >_NN CCL_NNP 2_CD >_NN CXCL_NNP 8_CD ._. In_IN non-_NN RA_NNP tissue_NN the_DT order_NN
          was_VBD ,_, CCL_NNP 3_CD >_NN CCL_NNP 5_CD >_NN CXCL_NNP 8_CD >_NN CCL_NNP 2_CD ._. The_DT number_NN of_IN
          CCL_NNP 3_CD and_CC CCL_NNP 5_CD positive_JJ intimal_NN cells_NNS did_VBD not_RB differ_VB
          between_IN RA_NNP and_CC non-_NN RA_NNP tissue_NN ._. However_RB ,_, the_DT number_NN of_IN
          intimal_NN cells_NNS binding_JJ CCL_NNP 2_CD in_IN RA_NNP was_VBD greater_JJR than_IN non-_NN RA_NNP
          synovium_NN ._. In_IN addition_NN ,_, there_EX were_VBD more_JJR cells_NNS binding_JJ
          CXCL_NNP 8_CD in_IN inflamed_JJ ,_, non-_NN RA_NNP intima_NN compared_VBN to_TO inflamed_JJ RA_NNP
          tissue_NN ._.
          Data_NNP were_VBD also_RB expressed_VBN as_IN the_DT percentage_NN of_IN intimal_NN
          cells_NNS binding_JJ chemokines_NNS (_( Supplementary_NNP Table_NNP 2_LS )_) ._. Similar_JJ
          results_NNS to_TO data_NNS expressed_VBD as_IN the_DT number_NN of_IN cells_NNS binding_JJ
          chemokines_NNS were_VBD obtained_VBN (_( Table_NNP 1_CD and_CC Supplementary_NNP Table_NNP
          2_LS )_) ._. In_IN both_DT RA_NNP and_CC non-_NN RA_NNP synovia_NN there_EX was_VBD a_DT
          significantly_RB higher_JJR percentage_NN of_IN positive_JJ cells_NNS in_IN
          inflamed_JJ compared_VBN to_TO noninflamed_JJ intima_NN ._. The_DT rank_NN order_NN
          of_IN chemokine_NN binding_JJ was_VBD almost_RB identical_JJ whether_IN the_DT
          data_NNS were_VBD expressed_VBN as_IN percentage_NN or_CC number_NN of_IN cells_NNS
          binding_JJ chemokines_NNS ._. In_IN the_DT cases_NNS of_IN CCL_NNP 2_CD ,_, CCL_NNP 3_CD and_CC CCL_NNP 5_CD
          there_EX were_VBD no_DT differences_NNS in_IN the_DT percentages_NNS of_IN positive_JJ
          cells_NNS between_IN RA_NNP and_CC non-_NN RA_NNP tissue_NN ._. A_DT higher_JJR percentage_NN
          of_IN cells_NNS ,_, however_RB ,_, bound_VBN CXCL_NNP 8_CD in_IN non-_NN RA_NNP inflamed_JJ intima_NN
          compared_VBN to_TO RA_NNP inflamed_JJ intima_NN ._.
        
        
          Chemokine_NNP binding_JJ to_TO neutrophils_NNS
          Neutrophils_NNP were_VBD present_JJ in_IN the_DT synovia_NN of_IN four_CD out_IN of_IN
          the_DT six_CD RA_NNP patients_NNS ,_, but_CC they_PRP were_VBD less_RBR abundant_JJ than_IN
          mononuclear_NN cells_NNS ._. Neutrophils_NNP were_VBD absent_JJ in_IN
          non-rheumatoid_JJ synovia_NN ._. Neutrophils_NNP were_VBD positive_JJ for_IN
          125_CD I-CXCL_NNP 8_CD binding_JJ (_( Fig_NNP ._. 2_LS )_) which_WDT was_VBD displaced_VBN in_IN the_DT
          presence_NN of_IN 1000_CD -_: fold_VB excess_JJ non-radiolabelled_JJ chemokine_NN ._.
          These_DT cells_NNS bound_VBN IL-_NNP 8_CD in_IN all_DT locations_NNS within_IN the_DT
          synovium_NN :_: within_IN blood_NN vessels_NNS ;_: close_RB to_TO blood_NN vessels_NNS in_IN
          the_DT extravascular_NN tissue_NN ;_: and_CC close_RB to_TO (_( or_CC at_IN )_) the_DT
          intimal_NN surface_NN ._. Neutrophils_NNP did_VBD not_RB show_VB any_DT signal_NN for_IN
          binding_JJ CCL_NNP 2_CD ,_, CCL_NNP 3_CD and_CC CCL_NNP 5_CD (_( Fig_NNP ._. 2_LS )_) ._. No_DT major_JJ
          differences_NNS in_IN neutrophil_NN chemokine_NN binding_JJ were_VBD apparent_JJ
          between_IN the_DT four_CD patients_NNS who_WP had_VBD these_DT cells_NNS in_IN their_PRP$
          synovia_NN ._.
        
        
          Immunolocalisation_NNP of_IN CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD
          To_TO define_VB the_DT molecular_JJ identity_NN of_IN the_DT 125_CD I-CXCL_NNP 8_CD
          binding_JJ sites_NNS on_IN synovial_NN macrophages_NNS and_CC neutrophils_NNS ,_,
          immunohistochemistry_NN was_VBD performed_VBN to_TO examine_VB expression_NN
          of_IN CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD by_IN these_DT cells_NNS ._. Sections_NNP from_IN the_DT same_JJ
          blocks_NNS of_IN synovia_NN used_VBN for_IN radiolabelled_JJ chemokine_NN
          binding_JJ were_VBD treated_VBN with_IN antibodies_NNS to_TO CXCR_NNP 1_CD ,_, CXCR_NNP 2_CD and_CC
          CD_NNP 68_CD ._. Samples_NNP from_IN every_DT RA_NNP and_CC non-_NN RA_NNP patient_NN showed_VBD
          expression_NN of_IN both_DT CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD by_IN macrophages_NNS in_IN the_DT
          subintima_NN and_CC intima_NN (_( Supplementary_NNP Fig_NNP ._. 2_LS and_CC Fig_NNP ._. 3_LS )_) ._.
          Similarly_RB ,_, in_IN RA_NNP samples_NNS that_WDT possessed_VBD neutrophils_NNS ,_,
          immunoreative_JJ CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD was_VBD displayed_VBN by_IN these_DT
          cells_NNS throughout_IN the_DT subintimal_NN and_CC intimal_NN layers_NNS ;_: the_DT
          staining_VBG intensity_NN for_IN CXCR_NNP 2_CD was_VBD more_RBR strong_JJ than_IN for_IN
          CXCR_NNP 1_CD (_( Fig_NNP ._. 3_LS c_SYM )_) ._. Sections_NNP treated_VBD with_IN rabbit_NN IgG_NNP instead_RB
          of_IN CXCR_NNP 1_CD or_CC CXCR_NNP 2_CD were_VBD negative_JJ for_IN macrophage_NN and_CC
          neutrophil_NN staining_VBG (_( Fig_NNP ._. 3_LS d_SYM )_) ._.
        
      
      
        Discussion_NNP
        The_DT results_NNS of_IN the_DT present_JJ study_NN show_NN the_DT presence_NN of_IN
        chemokine_NN binding_JJ sites_NNS on_IN macrophages_NNS and_CC neutrophils_NNS in_IN
        the_DT RA_NNP synovium_NN ._. These_DT sites_NNS were_VBD evident_JJ around_IN blood_NN
        vessels_NNS of_IN the_DT subintima_NN ,_, throughout_IN the_DT subintimal_NN stroma_NN
        and_CC in_IN the_DT intima_NN ._. In_IN RA_NNP there_EX is_VBZ increased_VBN recruitment_NN of_IN
        monocytes_NNS ,_, which_WDT migrate_VB into_IN the_DT synovial_NN subintima_NN and_CC to_TO
        the_DT intima_NN ,_, presumably_RB following_VBG a_DT chemotactic_JJ gradient_NN [_NN 3_CD
        ]_NN ._. The_DT increase_NN in_IN synovial_NN macrophage_NN numbers_NNS is_VBZ mainly_RB
        due_JJ to_TO enhanced_JJ recruitment_NN since_IN there_EX appears_VBZ to_TO be_VB
        little_JJ contribution_NN from_IN 
        in_IN situ_NN proliferation_NN of_IN these_DT cells_NNS
        [_NN 21_CD ]_NN ,_, although_IN deficient_NN apoptosis_NNS may_MD have_VB an_DT effect_NN on_IN
        increasing_VBG cell_NN number_NN [_NN 1_CD ]_NN ._. There_EX is_VBZ also_RB increased_VBN
        recruitment_NN of_IN neutrophils_NNS in_IN RA_NNP ,_, migrating_VBG from_IN subintimal_NN
        venules_NNS ,_, across_IN the_DT synovium_NN and_CC into_IN the_DT synovial_NN fluid_JJ
        where_WRB they_PRP can_MD occur_VB in_IN large_JJ numbers_NNS ._. The_DT binding_JJ of_IN CCL_NNP 2_CD ,_,
        CCL_NNP 3_CD ,_, CCL_NNP 5_CD and_CC CXCL_NNP 8_CD to_TO macrophages_NNS and_CC CXCL_NNP 8_CD binding_JJ to_TO
        neutrophils_NNS suggests_VBZ that_IN these_DT receptors_NNS may_MD be_VB involved_VBN
        in_IN signaling_VBG the_DT migration_NN of_IN the_DT phagocytes_NNS through_IN the_DT RA_NNP
        synovium_NN into_IN tissue_NN microcompartments_NNS and_CC fluid_JJ ._.
        The_DT finding_VBG that_IN the_DT proportion_NN and_CC percentage_NN of_IN
        chemokine_NN binding_JJ sites_NNS on_IN macrophages_NNS increases_NNS in_IN the_DT
        inflamed_JJ intima_NN of_IN RA_NNP and_CC non-_NN RA_NNP synovia_NN suggests_VBZ that_IN
        these_DT receptors_NNS may_MD function_VB in_IN chronic_JJ severe_JJ synovitis_NNS in_IN
        RA_NNP and_CC more_RBR mild_JJ synovitis_NNS associated_VBN with_IN joint_JJ damage_NN /_NN
        degeneration_NN in_IN non-_NN RA_NNP pathology_NN ._. In_IN the_DT cases_NNS of_IN CCL_NNP 2_CD ,_,
        CCL_NNP 3_CD and_CC CCL_NNP 5_CD there_EX were_VBD no_DT differences_NNS in_IN the_DT percentage_NN
        of_IN chemokine-positive_JJ cells_NNS in_IN inflamed_JJ regions_NNS of_IN the_DT RA_NNP
        and_CC non-_NN RA_NNP intima_NN ._. However_RB ,_, there_EX were_VBD fewer_JJR CXCL_NNP 8_CD positive_JJ
        cells_NNS in_IN the_DT inflamed_JJ RA_NNP intima_NN than_IN in_IN the_DT inflamed_JJ non-_NN RA_NNP
        intima_NN ._. The_DT RA_NNP synovia_NN were_VBD obtained_VBN from_IN patients_NNS with_IN
        long-standing_JJ disease_NN whereas_IN the_DT non-_NN RA_NNP samples_NNS were_VBD
        essentially_RB from_IN patients_NNS with_IN joint_JJ symptoms_NNS of_IN shorter_JJR
        duration_NN (_( Supplementary_NNP Table_NNP 1_LS )_) ._. One_CD explanation_NN is_VBZ that_IN
        there_EX may_MD be_VB temporal_JJ changes_NNS in_IN chemokine_NN receptor_NN
        expression_NN ,_, which_WDT could_MD explain_VB this_DT difference_NN between_IN RA_NNP
        and_CC non-_NN RA_NNP CXCL_NNP 8_CD binding_JJ ._. In_IN this_DT respect_NN ,_, temporal_JJ changes_NNS
        in_IN chemokine_NN expression_NN have_VBP been_VBN reported_VBN in_IN human_JJ RA_NNP and_CC
        an_DT animal_NN model_NN of_IN RA_NNP [_NN 22_CD 23_CD ]_NN ._. Alternatively_RB the_DT
        difference_NN in_IN CXCL_NNP 8_CD binding_JJ could_MD relate_VB to_TO variation_NN in_IN
        inflammatory_JJ mechanisms_NNS or_CC a_DT response_NN to_TO drug_NN treatment_NN in_IN
        the_DT RA_NNP group_NN ._.
        The_DT present_JJ experimental_JJ approach_NN was_VBD taken_VBN with_IN the_DT aim_NN
        of_IN finding_VBG out_IN if_IN receptors_NNS on_IN phagocytes_NNS bind_NN chemokines_NNS 
        in_IN situ_NN ,_, and_CC showed_VBD that_IN the_DT
        receptors_NNS are_VBP available_JJ and_CC functional_JJ in_IN terms_NNS of_IN binding_JJ
        chemokines_NNS ._. Our_PRP$ results_NNS agree_VBP with_IN 
        in_IN situ_NN studies_NNS in_IN human_JJ skin_NN ,_, where_WRB
        macrophages_NNS also_RB express_VBP binding_JJ sites_NNS for_IN radiolabelled_JJ
        CCL_NNP 3_CD ,_, CCL_NNP 5_CD and_CC CXCL_NNP 8_CD [_NN 24_CD 25_CD ]_NN ._. The_DT disadvantage_NN with_IN the_DT
        radioligand_NN technique_NN is_VBZ the_DT lack_NN of_IN definition_NN regarding_VBG
        the_DT molecular_JJ nature_NN of_IN the_DT receptors_NNS ._. In_IN contrast_NN ,_,
        immunohistochemistry_NN or_CC flow_NN cytometry_NN have_VBP the_DT advantage_NN
        of_IN molecular_JJ identification_NN ,_, but_CC can_MD not_RB show_VB definitively_RB
        if_IN the_DT receptors_NNS bind_NN ligands_NNS ._. Immunohistochemistry_NNP showed_VBD
        that_IN both_DT CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD were_VBD expressed_VBN by_IN synovial_NN
        macrophages_NNS and_CC neutrophils_NNS ,_, suggesting_VBG that_IN the_DT CXCL_NNP 8_CD
        binding_JJ sites_NNS on_IN these_DT cells_NNS were_VBD CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD ._.
        A_DT recent_JJ immunohistochemical_JJ study_NN has_VBZ shown_VBN the_DT
        presence_NN of_IN CCR_NNP 1_CD ,_, CCR_NNP 2_CD and_CC CCR_NNP 5_CD on_IN CD_NNP 68_CD +_NN macrophages_NNS in_IN the_DT
        RA_NNP synovium_NN ,_, but_CC not_RB CCR_NNP 4_CD [_NN 17_CD ]_NN ._. Since_IN CCL_NNP 2_CD is_VBZ a_DT ligand_NN
        for_IN CCR_NNP 2_CD ,_, and_CC both_DT CCL_NNP 3_CD and_CC CCL_NNP 5_CD are_VBP ligands_NNS for_IN both_DT CCR_NNP 1_CD
        and_CC CCR_NNP 5_CD [_NN 11_CD ]_NN ,_, these_DT receptors_NNS are_VBP probably_RB the_DT CC_NNP
        chemokine_NN binding_JJ sites_NNS on_IN the_DT macrophages_NNS in_IN the_DT present_JJ
        study_NN ._. The_DT lack_NN of_IN CCL_NNP 2_CD ,_, CCL_NNP 3_CD and_CC CCL_NNP 5_CD binding_JJ to_TO synovial_NN
        neutrophils_NNS suggests_VBZ little_JJ or_CC no_DT expression_NN of_IN the_DT
        corresponding_JJ CC_NNP chemokine_NN receptors_NNS on_IN these_DT cells_NNS ._. This_DT
        is_VBZ in_IN agreement_NN with_IN other_JJ studies_NNS showing_VBG lack_NN of_IN CCL_NNP 2_CD
        binding_JJ to_TO blood_NN neutrophils_NNS and_CC general_JJ lack_NN of_IN
        chemotactic_JJ response_NN of_IN these_DT cells_NNS to_TO CC_NNP chemokines_NNS [_NN 26_CD ]_NN
        ,_, although_IN recent_JJ reports_NNS indicate_VBP that_IN neutrophils_NNS ,_, in_IN
        response_NN to_TO certain_JJ cytokines_NNS ,_, are_VBP capable_JJ of_IN expressing_VBG CC_NNP
        chemokine_NN receptors_NNS [_NN 27_CD 28_CD ]_NN ._.
      
      
        Conclusion_NNP
        This_DT study_NN demonstrates_VBZ the_DT expression_NN of_IN available_JJ
        chemokine_NN binding_JJ sites_NNS for_IN CCL_NNP 2_CD ,_, CCL_NNP 3_CD ,_, CCL_NNP 5_CD and_CC CXCL_NNP 8_CD on_IN
        CD_NNP 68_CD +_NN macrophages_NNS in_IN the_DT subintimal_NN and_CC intimal_NN layers_NNS of_IN
        rheumatoid_NN and_CC nonrheumatoid_NN synovia_NN ._. Chemokine_NNP binding_JJ
        sites_NNS for_IN CXCL_NNP 8_CD ,_, but_CC not_RB for_IN CCL_NNP 2_CD ,_, CCL_NNP 3_CD or_CC CCL_NNP 5_CD ,_, were_VBD found_VBN
        on_IN neutrophils_NNS in_IN the_DT rheumatoid_NN synovium_NN ._. These_DT receptors_NNS
        may_MD mediate_VB the_DT recruitment_NN of_IN phagocytes_NNS to_TO the_DT subintima_NN ,_,
        intima_NN or_CC synovial_NN fluid_JJ and_CC could_MD provide_VB potential_JJ
        therapeutic_JJ targets_NNS ._.
      
      
        Supplementary_NNP material_NN
        
          Supplementary_NNP Materials_NNPS and_CC methods_NNS
        
        
          In_IN situbinding_VBG autoradiography_NN
          Synovia_NNP were_VBD cut_VBN into_IN approximately_RB 2_CD mm_NN 3_CD pieces_NNS ._. Four_CD
          samples_NNS were_VBD placed_VBN in_IN tubes_NNS containing_VBG 0_CD ._. 1_CD to_TO 4_CD ._. 0_CD ng_NN of_IN
          recombinant_JJ human_JJ 125_CD I-_NNP labeled_VBD (_( rh_NN 125_CD I_PRP )_) -_: CXCL_NNP 8_CD (_( M_NNP 
          r_LS =_SYM 8400_CD )_) ,_, rh_NN 125_CD I-CCL_NNP 5_CD (_( M_NNP 
          r_LS =_SYM 8000_CD )_) ,_, rh_NN 125_CD I-CCL_NNP 2_CD (_( M_NNP 
          r_LS =_SYM 8800_CD )_) or_CC rh_NN 125_CD I-CCL_NNP 3_CD (_( M_NNP 
          r_LS =_SYM 8000_CD )_) (_( 262_CD μCi_NN /_NN μg_NN ;_: NEN_NNP ,_, Boston_NNP ,_,
          USA_NNP )_) in_IN 400_CD μl_NN Hank_NNP 's_POS balanced_JJ salt_NN solution_NN containing_VBG
          0_CD ._. 1_CD %_NN bovine_JJ serum_NN albumin_NN and_CC 20_CD mM_NN HEPES_NNP ._. The_DT samples_NNS
          were_VBD then_RB incubated_JJ for_IN one_CD hour_NN at_IN room_NN temperature_NN on_IN a_DT
          platform_NN shaker_NN [_NN 19_CD ]_NN ._. In_IN these_DT experiments_NNS ,_, synovial_NN
          samples_NNS from_IN each_DT patient_NN were_VBD treated_VBN with_IN each_DT of_IN the_DT
          four_CD chemokines_NNS ._. Initial_JJ experiments_NNS showed_VBD that_IN binding_JJ
          sites_NNS were_VBD saturable_JJ over_IN this_DT concentration_NN range_NN and_CC
          the_DT optimum_JJ binding_JJ /_NN background_NN ratio_NN was_VBD obtained_VBN using_VBG
          0_CD ._. 8_CD ng_NN of_IN chemokine_NN ;_: this_DT amount_NN was_VBD used_VBN in_IN all_PDT the_DT
          subsequent_JJ experiments_NNS ._. Control_NN tubes_NNS contained_VBD 1000_CD -_: fold_VB
          excess_NN of_IN the_DT corresponding_JJ unlabeled_JJ recombinant_JJ human_JJ
          chemokine_NN (_( molecular_JJ mass_NN as_IN for_IN radiolabelled_JJ
          chemokines_NNS )_) (_( PeproTech_NNP EC_NNP ,_, London_NNP ,_, UK_NNP ;_: CXCL_NNP 8_CD was_VBD kindly_RB
          donated_VBN from_IN Novartis_NNP Research_NNP Institute_NNP ,_, Vienna_NNP ,_,
          Austria_NNP )_) ._. The_DT tissue_NN was_VBD washed_VBN four_CD times_NNS for_IN 10_CD min_NN in_IN
          2_CD ml_NN Hank_NNP 's_POS balanced_JJ salt_NN solution_NN on_IN a_DT platform_NN shaker_NN ,_,
          then_RB fixed_VBN overnight_JJ in_IN 4_CD %_NN paraformaldehyde_NN ._. It_PRP was_VBD then_RB
          dehydrated_JJ in_IN alcohol_NN ,_, embedded_VBN in_IN fibrowax_NN and_CC sectioned_JJ
          at_IN 5_CD μm_NN thickness_NN ._. Sections_NNP were_VBD deparafinized_JJ ,_,
          rehydrated_JJ ,_, air-dried_JJ and_CC coated_VBN with_IN Amersham_NNP LM_NNP 1_CD
          emulsion_NN (_( Amersham_NNP Pharmacia_NNP Biotech_NNP ,_, Little_NNP Chalfont_NNP ,_,
          UK_NNP )_) ._. The_DT slides_NNS were_VBD exposed_VBN at_IN 4_CD °_NN C_NNP for_IN two_CD weeks_NNS ,_,
          developed_VBN and_CC stained_JJ in_IN haematoxylin_NN and_CC eosin_NN ._.
        
        
          Immunohistochemistry_NNP for_IN CXCR_NNP 1_CD and_CC CXCR_NNP 2_CD
          Sections_NNP were_VBD deparafinized_JJ ,_, rehydrated_JJ and_CC in_IN the_DT
          case_NN of_IN CXCR_NNP 1_CD pre-treated_JJ with_IN 1_CD %_NN pronase_NN for_IN 10_CD min_NN to_TO
          unmask_VB epitopes_NNS ._. Following_VBG blocking_VBG of_IN endogenous_JJ
          peroxidase_NN with_IN 0_CD ._. 3_CD %_NN hydrogen_NN peroxide_NN in_IN methanol_NN for_IN 30_CD
          min_NN ,_, slides_NNS were_VBD rinsed_JJ in_IN PBS_NNP and_CC treated_VBN with_IN a_DT 1_CD /_NN 60_CD
          dilution_NN of_IN normal_JJ goat_NN serum_NN for_IN 30_CD min_NN ._. Sections_NNP were_VBD
          rinsed_JJ in_IN PBS_NNP ,_, incubated_JJ with_IN CXCR_NNP 1_CD or_CC CXCR_NNP 2_CD antibodies_NNS
          (_( at_IN 1_CD /_NN 50_CD and_CC 1_CD /_NN 500_CD dilution_NN respectively_RB )_) or_CC rabbit_NN IgG_NNP
          (_( at_IN the_DT same_JJ concentration_NN as_IN primary_JJ antibodies_NNS )_) for_IN 30_CD
          min_NN ._. After_IN washing_VBG with_IN PBS_NNP ,_, the_DT antibodies_NNS were_VBD detected_VBN
          using_VBG reagents_NNS in_IN the_DT Vectastain_NNP ABC_NNP Elite_NNP Kit_NNP (_( Vector_NNP
          Labs_NNPS ,_, Burlingame_NNP ,_, USA_NNP )_) ;_: the_DT sections_NNS were_VBD treated_VBN with_IN
          biotinylated_JJ goat_NN anti-rabbit_JJ IgG_NNP (_( at_IN 1_CD /_NN 200_CD dilution_NN )_) for_IN
          30_CD min_NN ,_, rinsed_JJ with_IN PBS_NNP ,_, incubated_JJ with_IN
          streptavidin-conjugated_JJ peroxidase_NN for_IN 30_CD min_NN ,_, washed_VBN
          with_IN PBS_NNP ,_, then_RB treated_VBN with_IN the_DT chromogen_NN
          3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN for_IN 5_CD min_NN ._. Sections_NNP were_VBD washed_VBN
          twice_RB in_IN PBS_NNP then_RB water_NN ,_, dried_VBD and_CC counter-stained_JJ in_IN
          Mayer_NNP 's_POS haematoxylin_NN ._. All_DT steps_NNS in_IN the_DT method_NN were_VBD
          carried_VBN out_RB at_IN room_NN temperature_NN ._.
        
        
          Quantitation_NNP of_IN synovial_NN sections_NNS
          Sections_NNP were_VBD used_VBN from_IN 
          in_IN situ_NN binding_JJ autoradiography_NN
          experiments_NNS and_CC were_VBD quantitated_JJ blind_JJ by_IN one_CD observer_NN ._.
          The_DT sample_NN length_NN was_VBD 280_CD μm_NN of_IN synovial_NN intima_NN ,_, the_DT
          width_NN of_IN a_DT field_NN of_IN view_NN using_VBG a_DT ×_NN 63_CD objective_NN lens_NN on_IN a_DT
          Nikon_NNP diaplan_NN light_JJ microscope_NN ._. Intimal_NNP cells_NNS were_VBD scored_VBN
          as_IN being_VBG positive_JJ for_IN chemokine_NN binding_VBG when_WRB the_DT
          autoradiographic_JJ signal_NN was_VBD greater_JJR than_IN that_DT of_IN the_DT
          adjacent_JJ background_NN ._. The_DT number_NN of_IN positive_JJ and_CC negative_JJ
          cells_NNS were_VBD counted_VBN visually_RB in_IN three_CD sample_NN lengths_NNS per_IN
          section_NN (_( i_NNP ._. e_SYM ._. 840_CD μm_NN )_) ._. The_DT number_NN of_IN sections_NNS per_IN patient_NN
          was_VBD four_CD ,_, giving_VBG a_DT total_NN of_IN 3360_CD μm_NN of_IN intima_NN measured_VBN
          per_IN patient_NN ._. The_DT intima_NN was_VBD noted_VBN as_IN being_VBG normal_JJ where_WRB
          it_PRP was_VBD one_CD to_TO two_CD cells_NNS thick_JJ ,_, and_CC inflamed_JJ where_WRB greater_JJR
          than_IN two_CD cells_NNS thick_JJ ._. All_DT cells_NNS were_VBD counted_VBN except_IN
          neu-trophils_JJ ,_, which_WDT only_RB comprised_VBN <_NN 1_CD %_NN of_IN all_DT cells_NNS
          sampled_VBN ._.
          From_IN these_DT data_NNS ,_, the_DT number_NN and_CC percentage_NN of_IN positive_JJ
          cells_NNS in_IN the_DT intimal_NN samples_NNS were_VBD obtained_VBN and_CC expressed_VBN
          per_IN 500_CD μm_NN of_IN intima_NN ._. Statistical_NNP analyses_NNS were_VBD by_IN
          Student_NNP 's_POS 
          t_NN -_: test_NN ,_, The_DT result_NN was_VBD significant_JJ
          when_WRB 
          P_NN <_NN 0_CD ._. 05_CD ._.
        
      
      
        Supplementary_NNP Discussion_NNP
        The_DT functional_JJ role_NN of_IN chemokine_NN receptors_NNS in_IN
        inflammatory_JJ cell_NN recruitment_NN is_VBZ suggested_VBN from_IN animal_NN
        models_NNS of_IN RA_NNP ._. Using_VBG the_DT CC_NNP chemokine_NN receptor_NN antagonist_NN
        MCP-_NNP 1_CD (_( 9_CD -_: 76_CD )_) ,_, a_DT truncated_JJ analogue_NN peptide_NN corresponding_JJ to_TO
        MCP_NNP ,_, markedly_RB reduces_VBZ joint_JJ histopathology_NN and_CC symptoms_NNS in_IN
        the_DT MRL-_NNP 
        lpr_NN mouse_NN model_NN [_NN S_NNP 1_CD ]_NN ._. The_DT CC_NNP
        receptor_NN antagonist_NN MetRANTES_NNP decreased_VBD the_DT incidence_NN and_CC
        severity_NN of_IN arthritis_NN in_IN mouse_NN collagen-induced_JJ arthritis_NN [_NN
        S_NNP 2_CD ]_NN ._. With_IN both_DT antagonists_NNS ,_, mononuclear_NN infiltration_NN is_VBZ
        reduced_VBN ._.
        CCL_NNP 2_CD ,_, CCL_NNP 3_CD ,_, CCL_NNP 5_CD and_CC CXCL_NNP 8_CD occur_VB in_IN human_JJ RA_NNP synovial_NN
        fluid_NN and_CC tissue_NN [_NN 8_CD ]_NN ._. Therefore_RB the_DT ligands_NNS for_IN the_DT
        binding_JJ sites_NNS described_VBD here_RB occur_VB endogenously_RB within_IN the_DT
        RA_NNP joint_NN ,_, adding_VBG further_JJ evidence_NN towards_IN a_DT role_NN for_IN these_DT
        receptors_NNS 
        in_IN vivo_NN ._. In_IN the_DT RA_NNP joint_JJ the_DT
        synovial_NN macrophage_NN is_VBZ among_IN the_DT principle_NN cell_NN types_NNS that_WDT
        produce_VBP CCL_NNP 2_CD ,_, CCL_NNP 3_CD and_CC CXCL_NNP 8_CD [_NN 8_CD 17_CD ]_NN ._. The_DT finding_NN of_IN
        chemokine_NN receptors_NNS on_IN these_DT cells_NNS suggests_VBZ that_IN
        macrophages_NNS may_MD amplify_VB inflammation_NN by_IN attracting_VBG cells_NNS of_IN
        the_DT same_JJ type_NN ,_, and_CC other_JJ cell_NN types_NNS ,_, into_IN the_DT joint_NN thereby_RB
        setting_VBG up_RP a_DT positive_JJ feedback_NN loop_NN ._. Similar_JJ mechanisms_NNS may_MD
        also_RB be_VB occurring_VBG with_IN neutrophils_NNS ,_, since_IN in_IN the_DT RA_NNP joint_JJ
        these_DT cells_NNS produce_VBP CXCL_NNP 8_CD [_NN S_NNP 3_CD ]_NN and_CC express_VB CXCL_NNP 8_CD binding_JJ
        sites_NNS ._.
      
      
        Abbreviations_NNP
        CC_NNP =_SYM chemokine_NN with_IN two_CD adjacent_JJ cysteine_NN (_( C_NNP )_) residues_NNS
        near_IN the_DT NH_NNP 
        2_CD -_: terminus_JJ ;_: CCR_NNP =_SYM CC_NNP chemokine_NN
        receptor_NN ;_: CXC_NNP =_SYM chemokine_NN with_IN C_NNP separated_VBN by_IN an_DT amino_JJ acid_NN
        defined_VBN as_IN X_NNP ;_: CXCR_NNP =_SYM CXC_NNP chemokine_NN receptor_NN ;_: IL_NNP =_SYM
        interleukin_NN ;_: PBS_NNP =_SYM phosphate-buffered_JJ saline_NN ;_: RA_NNP =_SYM
        rheumatoid_NN arthritis_NN ;_: RANTES_NNP =_SYM regulated_VBN on_IN activation_NN
        normal_JJ T_NN cell_NN expressed_VBD and_CC secreted_JJ ;_: rh_NN =_SYM recombinant_JJ
        human_NN ._.
      
    
  
